|
CCDC142 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.193900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.306500E-02 |
| Normal-vs-Stage2 |
6.241900E-02 |
| Normal-vs-Stage3 |
9.908300E-02 |
| Normal-vs-Stage4 |
3.609200E-01 |
| Stage1-vs-Stage2 |
2.413600E-01 |
| Stage1-vs-Stage3 |
5.011600E-01 |
| Stage1-vs-Stage4 |
9.338400E-01 |
| Stage2-vs-Stage3 |
5.005000E-01 |
| Stage2-vs-Stage4 |
4.516400E-01 |
| Stage3-vs-Stage4 |
7.653600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.517900E-03 |
| Normal-vs-AfricanAmerican |
2.563900E-02 |
| Normal-vs-Asian |
6.347400E-01 |
| Caucasian-vs-AfricanAmerican |
7.793000E-01 |
| Caucasian-vs-Asian |
5.922400E-01 |
| AfricanAmerican-vs-Asian |
5.543800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.721400E-03 |
| Normal-vs-Female |
1.061920E-03 |
| Male-vs-Female |
1.252430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.126440E-01 |
| Normal-vs-Extreme_Weight |
3.602800E-01 |
| Normal-vs-Obese |
8.239600E-03 |
| Normal-vs-Extreme_Obese |
4.460000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.156200E-01 |
| Normal_Weight-vs-Obese |
3.879800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.393400E-01 |
| Extreme_Weight-vs-Obese |
6.140100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.007000E-01 |
| Obese-vs-Extreme_Obese |
5.781000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.057000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.554010E-04 |
| Normal-vs-Age(61-80Yrs) |
5.290200E-02 |
| Normal-vs-Age(81-100Yrs) |
8.100200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.842800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.240030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.722200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.297700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.483500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.272400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.646180E-04 |
| Normal-VS-Type2 PRCC |
9.787600E-01 |
| Normal-VS-KIRP CIMP |
1.205150E-01 |
| Normal-VS-Unclassified PRCC |
1.052270E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.538400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.211400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.470800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.061160E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.268140E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.998400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.569800E-01 |
| Normal-vs-N1 |
4.066100E-02 |
| Normal-vs-N2 |
3.439000E-01 |
| N0-vs-N1 |
1.499360E-01 |
| N0-vs-N2 |
2.738000E-01 |
| N1-vs-N2 |
9.155200E-01 |
|
|
